Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Pharmacyclics Inc (PCYC)    
$256.59 0.51 (0.2%) as of 4:30 Fri 4/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 73,583,000 as of 6/30
Market Cap: 18.88(B)
Last Volume: 615,134 Avg Vol: 877,099
52 Week Range: $85.85 - $258.85
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Pharmacyclics is a biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. Co. has three proprietary drug candidates under clinical development and several preclinical lead molecules: an inhibitor of Bruton's tyrosine kinase (BTK) ibrutinib in several Phase III studies in hematologic malignancies, a BTK inhibitor lead optimization program targeting anti-inflammatory and autoimmune indications, an inhibitor of Factor VIIa in a Phase II clinical trial in pancreatic cancer and a histone deacetylase inhibitor, abexinostat, in Phase I and II clinical trials in solid tumors and hematological malignancies.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 58,514 99,496 161,058 500,894
Total Sell Value $14,873,213 $20,417,506 $27,902,944 $67,753,054
Total People Sold 3 5 6 13
Total Sell Transactions 4 11 17 38
End Date 2015-01-25 2014-10-24 2014-04-25 2013-04-25

   
Records found: 401
  Page 1 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Tan Heow Chief Quality&Tech Operations   •       –      –    2015-04-13 4 OE $27.05 $99,977 D/D 3,696 11,462     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2015-03-17 4 OE $27.05 $99,977 D/D 3,696 7,766     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2015-03-13 4 S $254.88 $870,756 D/D (3,416) 54,611 -0%     
   Tan Heow Chief Quality&Tech Operations   •       –      –    2015-03-12 4 OE $27.05 $27,050 D/D 1,000 5,070     -
   Tan Heow Chief Quality&Tech Operations   •       –      –    2015-03-12 4 S $254.51 $254,506 D/D (1,000) 4,070 -1%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2015-03-12 4 OE $0.75 $69,375 D/D 92,500 317,812     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2015-03-12 4 OE $2.30 $110,904 D/D 48,219 366,031     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2015-03-12 4/A OE $0.75 $180,279 D/D 140,719 366,031     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2015-03-11 4 OE $61.60 $1,808,849 D/D 24,098 82,125     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2015-03-11 4 S $254.11 $7,623,444 D/D (30,000) 225,312 -1%     
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2015-03-11 4 S $254.15 $6,124,507 D/D (24,098) 58,027 -1%     
   Zanganeh Maky Chief Operating Officer   •       –      –    2015-03-11 4 OE $7.19 $215,700 D/D 30,000 255,312     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2015-03-03 4 D $216.77 $560,121 D/D (2,584) 58,027     -
   Booth Robert F. Director   –       •      –    2015-01-22 4 A $0.00 $0 D/D 10,000 10,000     -
   Zanganeh Maky Chief Operating Officer   •       –      –    2015-01-16 4 A $0.00 $0 D/D 15,000 225,312     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2015-01-16 4 A $0.00 $0 D/D 22,000 60,611     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-12-05 5 D $0.00 $0 I/I (200,740) 170,379     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-12-04 5 GD $0.00 $0 D/D 617 13,382,951     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-12-03 5 GD $0.00 $0 D/D 2,000 13,383,568     -
   Tomasello Shawn Chief Commercial Officer   •       –      –    2014-11-19 4 D $138.37 $745,801 D/D (5,390) 57,110     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-11-19 5 GD $0.00 $0 D/D 35,517 13,385,568     -
   Duggan Robert W Chairman and CEO   •       •       •   2014-11-18 5 GD $0.00 $0 D/D 2,000 13,421,085     -
   Fardis Maria Chief of Oncology Ops & Allian   •       –      –    2014-11-13 4 OE $6.84 $20,520 D/D 3,000 6,193     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-11-13 4 OE $61.60 $61,600 D/D 1,000 39,611     -
   Soni Manmeet Singh Chief Financial Officer   •       –      –    2014-11-13 4 S $141.44 $141,442 D/D (1,000) 38,611 -87%     

  401 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed